355 related articles for article (PubMed ID: 16788938)
1. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?
Park SS; Park JM; Kim JH; Kim WB; Lee J; Kim SJ; Kim CS; Mok YJ
J Surg Oncol; 2006 Jul; 94(1):16-20. PubMed ID: 16788938
[TBL] [Abstract][Full Text] [Related]
2. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
3. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement.
Kunisaki C; Shimada H; Yamaoka H; Takahashi M; Ookubo K; Akiyama H; Nomura M; Moriwaki Y
Hepatogastroenterology; 2000; 47(32):586-9. PubMed ID: 10791244
[TBL] [Abstract][Full Text] [Related]
4. Limited effectiveness of extended lymph-node dissection for node-negative patients with proximal gastric cancer.
Kikuchi S; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Sato K; Kakita A
Anticancer Res; 2001; 21(2B):1359-62. PubMed ID: 11396213
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
6. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
7. Appropriate gastric resection with lymph node dissection for early gastric cancer.
Borie F; Plaisant N; Millat B; Hay JM; Fagniez PL;
Ann Surg Oncol; 2004 May; 11(5):512-7. PubMed ID: 15078634
[TBL] [Abstract][Full Text] [Related]
8. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
[TBL] [Abstract][Full Text] [Related]
10. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer.
Fotia G; Marrelli D; De Stefano A; Pinto E; Roviello F
Eur J Surg Oncol; 2004 Nov; 30(9):930-4. PubMed ID: 15498636
[TBL] [Abstract][Full Text] [Related]
12. Better prognosis of T2 gastric cancer with preoperative diagnosis of early gastric cancer.
Tokunaga M; Hiki N; Fukunaga T; Ohyama S; Yamada K; Yamaguchi T
Ann Surg Oncol; 2009 Jun; 16(6):1514-9. PubMed ID: 19290492
[TBL] [Abstract][Full Text] [Related]
13. Significance of para-aortic lymph node dissection in advanced gastric cancer.
Kunisaki C; Shimada H; Yamaoka H; Wakasugi J; Takahashi M; Akiyama H; Nomura M; Moriwaki Y
Hepatogastroenterology; 1999; 46(28):2635-42. PubMed ID: 10522056
[TBL] [Abstract][Full Text] [Related]
14. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.
Smith DD; Schwarz RR; Schwarz RE
J Clin Oncol; 2005 Oct; 23(28):7114-24. PubMed ID: 16192595
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
16. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
Ann Surg Oncol; 2007 May; 14(5):1688-93. PubMed ID: 17245613
[TBL] [Abstract][Full Text] [Related]
18. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
[TBL] [Abstract][Full Text] [Related]
19. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection.
Biffi R; Botteri E; Cenciarelli S; Luca F; Pozzi S; Valvo M; Sonzogni A; Chiappa A; Leal Ghezzi T; Rotmensz N; Bagnardi V; Andreoni B
Eur J Surg Oncol; 2011 Apr; 37(4):305-11. PubMed ID: 21288685
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer.
Gunji Y; Suzuki T; Kobayashi S; Hori S; Hayashi H; Shimada H; Matsubara H; Nabeya Y; Ochiai T
Hepatogastroenterology; 2003; 50(52):1178-82. PubMed ID: 12846009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
